Amar Gajjar
St. Jude Children's Research Hospital · Pediatric Brain Tumor Consortium
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amar Gajjar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:43 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05952687 · Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid TumorsSt. Jude Children's Research Hospital · withdrawn · Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS · principal investigator
- Ph1NCT03696355 · Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline GliomasSt. Jude Children's Research Hospital · completed · Brain and Central Nervous System Tumors · principal investigator
- Ph2NCT02114229 · Phase 2 Study of Alisertib Therapy for Rhabdoid TumorsSt. Jude Children's Research Hospital · active not recruiting · Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor · principal investigator
- Ph2NCT01878617 · A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed MedulloblastomaSt. Jude Children's Research Hospital · active not recruiting · Medulloblastoma · principal investigator
- Ph2NCT01239316 · Vismodegib in Treating Younger Patients With Recurrent or Refractory MedulloblastomaNational Cancer Institute (NCI) · completed · Recurrent Childhood Medulloblastoma · principal investigator
- Ph2NCT00939484 · Vismodegib in Treating Patients With Recurrent or Refractory MedulloblastomaNational Cancer Institute (NCI) · completed · Adult Medulloblastoma · principal investigator
- N/ANCT00897286 · Study of Stored Tumor Samples in Young Patients With Brain TumorsSt. Jude Children's Research Hospital · terminated · Brain and Central Nervous System Tumors · principal investigator
- Ph1NCT00822458 · GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous TreatmentNational Cancer Institute (NCI) · completed · Recurrent Childhood Medulloblastoma · principal investigator
- Ph2NCT00602667 · Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or EpendymomaSt. Jude Children's Research Hospital · active not recruiting · Brain and Central Nervous System Tumors · study chair
- Ph3NCT00085202 · Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorSt. Jude Children's Research Hospital · completed · Brain and Central Nervous System Tumors · principal investigator
- Ph3NCT00002875 · Radiation Therapy Plus Combination Chemotherapy in Treating Children With MedulloblastomaChildren's Oncology Group · completed · Brain Tumors, Central Nervous System Tumors · study chair
- Ph2NCT00003211 · Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal TumorSt. Jude Children's Research Hospital · completed · Brain and Central Nervous System Tumors · study chair
- Ph2NCT00004068 · Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain TumorSt. Jude Children's Research Hospital · completed · Brain and Central Nervous System Tumors · study chair
- Ph1NCT00052780 · Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsNational Cancer Institute (NCI) · completed · Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor, Childhood Craniopharyngioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Prophylactic Multimodal Cognitive Intervention for Children with Medulloblastoma (Resubmission)R01CA187079 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HEATHER M CONKLIN · fiscal years 2015 to 2019Named on NCT01878617
- Pediatric Brain Tumor Consortium (PBTC)U01CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI JAMES Milford BOYETT · fiscal years 2000 to 2013
- Anticancer Drug Pharmacology in Very Young ChildrenR01CA154619 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CLINTON F STEWART · fiscal years 2012 to 2016Named on NCT00602667
- Cancer Biology (CBP)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Douglas R. Green · fiscal years 2000 to 2026Named on NCT00004068
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:43 UTC. The ranking covers the 200 most relevant of 102 PubMed records, and a shared surname and initials can bring in a namesake. All 102 on PubMed
- Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.J Clin Oncol · 2006732 citationsRCR 17.0
- 727 citationsRCR 15.7
- 339 citationsRCR 9.4
- Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.J Neurosurg · 2006274 citationsRCR 7.7
- Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.Neuro Oncol · 2013217 citationsRCR 6.7
- Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.Lancet Oncol · 2018208 citationsRCR 7.1
- Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).J Clin Oncol · 2021201 citationsRCR 11.3
- Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.J Clin Oncol · 2021179 citationsRCR 10.2
- Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.Clin Cancer Res · 2013173 citationsRCR 4.5
- 139 citationsRCR 3.5